The Influence of Familial Predisposition to Cardiovascular Complications upon Childhood Obesity Treatment
March
The Influence of Familial Predisposition to Cardiovascular Complications upon Childhood Obesity Treatment
Louise A. Nielsen 0 1
Christine Bjse 0 1
Julie T. Kloppenborg 0 1
Caecilie Trier 0 1
Michael Gamborg 0 1
Jens-Christian Holm 0 1
0 1 The Children's Obesity Clinic, Department of Paediatrics, Copenhagen University Hospital Holbaek , DK 4300, Holbaek , Denmark , 2 Department of Paediatrics, Copenhagen University Hospital Herlev , DK 2730, Herlev , Denmark , 3 The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen , DK 2200, Copenhagen , Denmark , 4 Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals , The Capital Region, DK 2000, Frederiksberg, Copenhagen , Denmark , 5 University of Copenhagen, Faculty of Health and Medical Sciences , DK 2200, Copenhagen , Denmark
1 Academic Editor: Yvonne Bottcher, University of Leipzig , GERMANY
-
Funding: This study is part of research activities in
TARGET (The impact of our genomes on individual
treatment response in obese children, see www.
target.ku.dk) and BIOCHILD (Genetics and systems
biology of childhood obesity in India and Denmark,
see (www.biochild.ku.dk)) consortia supported by the
Region Zealand Health Scientific Research
Foundation (see, http://www.regionsjaelland.dk/
Sundhed/forskning/forskningsfinansiering/Sider/
The aim was to investigate whether a familial predisposition to obesity related
cardiovascular complications was associated with the degree of obesity at baseline and/or changes in
the degree of obesity during a multidisciplinary childhood obesity treatment program.
The study included 1421 obese children (634 boys) with a median age of 11.5 years (range
3.117.9 years), enrolled in treatment for 0.04 to 5.90 years (median 1.3 years) at the
Children's Obesity Clinic, Denmark. At baseline, weight and height were measured, body mass
index (BMI) standard deviation score (SDS) calculated, and self-reported information on
familial predisposition to obesity, hypertension, type 2 diabetes mellitus (T2DM),
thromboembolic events, and dyslipidaemia were obtained. A familial predisposition included events in
biological parents, siblings, grandparents, uncles, and aunts. The treatment outcomes were
categorically analysed according to the prevalence of familial predispositions.
The median BMI SDS at enrolment was 3.2 in boys and 2.8 in girls.
One-thousand-andforty-one children had obesity in their family, 773 had hypertension, 551 had T2DM, 568
had thromboembolic events, and 583 had dyslipidaemia. Altogether, 733 had three or more
predispositions. At baseline, familial T2DM was associated with a higher mean BMI SDS
dren's degree of obesity. During treatment, girls with familial obesity lost more weight,
oekonomi.aspx) and the Danish Council for Strategic
Research (grant 11-115917 and 11-116714) (see,
http://ufm.dk/en/research-and-innovation/councilsand-commissions/the-danish-council-for-strategicresearch). Funding was received by J-CH. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
compared to girls without familial obesity (p = 0.04). No other familial predispositions were
associated with changes in BMI SDS during treatment.
Obese children with a familial predisposition to T2DM showed a significantly higher degree
of obesity at baseline and girls with familial obesity responded better to treatment. Besides
these findings, no other associations were found between the occurrence of familial
predispositions and the degree of obesity or changes herein during multidisciplinary childhood
obesity treatment.
Through the past few decades, the prevalence of obesity in children and adolescents has
increased though new studies suggest that the prevalence may have reached a plateau;
nevertheless, obesity represents a serious challenge to the public health worldwide [1,2]. Childhood
obesity is associated with severe comorbidities in regards to metabolic complications, such as
dyslipidaemia, hypertension, insulin resistance, and prediabetes [36]. Furthermore, obese
children are at risk of developing coronary heart disease and remaining obese as adults [3,7].
In order to treat childhood obesity effectively, an early intervention is of great importance,
and a multidisciplinary approach involving the family combining counselling on diet,
behaviour, and activity seems pivotal, but the response to treatment may be inadequate for some
patients [813]. One explanation may be the metabolic state of the children and their families,
since it has been shown that a familial predisposition to obesity is associated with a poorer
response to treatment [9,10,12,14]. Furthermore, a familial predisposition to obesity has been
associated with the development of obesity in childhood [1518]. The influence of a familial
predisposition to obesity has been described in regards to parents [9,11,12,1416] especially
the weight status of the mother [9,11,15], siblings [10], and grandparents [17,18] indicating
that the high prevalence of overweight and obese children is dependent upon obesity among
the family members.
The knowledge regarding the influence of familial type 2 diabetes mellitus (T2DM) and
cardiovascular disease (CVD) upon the degree of obesity in later generations is less established. At
present, the literature outlines that adolescents with T2DM show a tendency of being obese
and having a familial predisposition to T2DM [19], but this particular familial predisposition
has not been shown to influence the treatment outcome in obese children [12]. In addition,
parental T2DM and hypertension have been associated with increased weight and skinfold
thickness in a large cohort of children [20], whereas another study shows that children with a family
history of CVD are more obese and that children suffering from metabolic complications also
exhibit a higher prevalence of the very same complications in their families [21].
The present study investigated the association between body mass index (BMI) standard
deviation score (SDS) and a familial predisposition to obesity, hypertension, T2DM,
thromboembolic events, and dyslipidaemia in obese children and adolescents enrolled in a
multidisciplinary childhood obesity treatment program. The study investigated whether these familial
predispositions influenced the degree of obesity at baseline or the changes in BMI SDS
during treatment.
Materials and Methods
Study population
This prospective study was based on 1732 children and adolescents enrolled in treatment at
The Childrens Obesity Clinic, Department of Paediatrics, Copenhagen University Hospital
Holbaek, Denmark. The children had a BMI above the 90th percentile adjusted for age and
gender and were enrolled in the clinic from January 2008 to January 2014. Of th (...truncated)